Where does Jan Møller Mikkelsen work?

Jan Møller Mikkelsen is President at Ascendis Pharma A/S.

What check size does Jan Møller Mikkelsen write?

Jan Møller Mikkelsen typically writes checks of $10M – $50M.

Jan Møller Mikkelsen

Investor

President at Ascendis Pharma A/S

San Francisco Bay Area

Writes $10M – $50M checks · typically $25M

About

Jan Møller Mikkelsen is President and Chief Executive Officer of Ascendis Pharma A/S, which he founded in 2007. The biopharmaceutical company develops therapies using its TransCon technology platform, with a pipeline including three endocrinology rare disease candidates in clinical development and an oncology program. Ascendis has achieved positive Phase 3 results for TransCon hGH and is preparing a Biologics License Application submission.

Experience

Ascendis Pharma A/SPresident and Chief Executive Officercurrent2007 — present
LifeCycle Pharma A/SPresident and Chief Executive Officer2002 — 2006Denmark
Maxygen, Inc.President, Protein Pharmaceutical Division2000 — 2002Denmark and Redwood City, CA
ProFound A/SCo-Founder and co-Chief Executive Officer1999 — 2000Denmark
Novo NordiskVice President, Protein Discovery1991 — 1999Denmark
Novo NordiskManager, Enzyme Structure1989 — 1991Denmark
Nordisk GentofteResearch Scientist1987 — 1989Denmark

Education

Odense UniversityCand. Scient., Biochemistry
Children’s Hospital OaklandPost-doctoral research, Biochemistry1985 — 1986

Network1

George Whitesides

Chief Scientific Advisor at Material Impact

Investors connected to Jan in public investor directories — a warm-intro map.

Frequently asked questions

Where does Jan Møller Mikkelsen work?: Jan Møller Mikkelsen is President at Ascendis Pharma A/S.
What check size does Jan Møller Mikkelsen write?: Jan Møller Mikkelsen typically writes checks of $10M – $50M.